| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 TAS2R30 OR2F1 OR2T11 GRM7 F2RL1 GRM8 OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 1.42e-25 | 884 | 84 | 35 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2W3 NPFFR2 CMKLR2 CHRNA6 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 HCAR1 MC2R TMEM63B OR5B21 OR1L6 GPR135 OR14I1 NMUR1 HTR3C OR4D11 TAS2R30 OR2F1 OR2T11 GRM7 F2RL1 GRM8 SLC22A17 OR13J1 OR6X1 CX3CR1 HCRTR1 CHRND CXCR2 OR8G2P OR2A2 | 8.26e-25 | 1353 | 84 | 40 | GO:0004888 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E SLC22A18 CHRNA6 TMC1 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 ABCA13 SLCO1A2 SLC44A2 TMEM63B SLC28A1 MTTP ABCC11 SLC15A5 SLCO1B3 SLC36A3 SLC35F2 ATP11C HTR3C GRM7 SLC29A1 SLC22A17 CHRND | 1.63e-13 | 1289 | 84 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E SLC22A18 CHRNA6 TMC1 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 ABCA13 SLCO1A2 SLC44A2 TMEM63B SLC28A1 ABCC11 SLC15A5 SLCO1B3 SLC36A3 SLC35F2 HTR3C GRM7 SLC29A1 SLC22A17 CHRND | 1.12e-12 | 1180 | 84 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2W3 OR2F2 OR8J3 OR10A7 OR11G2 OR6C2 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 2.38e-12 | 431 | 84 | 17 | GO:0004984 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A4 SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 SLCO1A2 SLC44A2 SLC28A1 SLC15A5 SLCO1B3 SLC36A3 SLC29A1 | 3.13e-10 | 296 | 84 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A4 SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 ABCA13 SLCO1A2 SLC44A2 SLC28A1 ABCC11 SLC15A5 SLCO1B3 SLC36A3 SLC29A1 | 1.24e-09 | 477 | 84 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B HTR3C GRM7 CHRND | 1.99e-07 | 343 | 84 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | symporter activity | SLC6A4 SLC22A18 SLC24A4 SLC36A4 SLC28A1 SLC15A5 SLC36A3 SLC29A1 | 2.26e-07 | 150 | 84 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.89e-07 | 70 | 84 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B SLC28A1 SLC36A3 HTR3C GRM7 SLC29A1 CHRND | 6.52e-07 | 664 | 84 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.40e-06 | 46 | 84 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.47e-06 | 133 | 84 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.07e-06 | 140 | 84 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B HTR3C GRM7 CHRND | 3.45e-06 | 459 | 84 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B SLC28A1 SLC36A3 HTR3C GRM7 SLC29A1 CHRND | 5.20e-06 | 793 | 84 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 5.92e-06 | 9 | 84 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 5.92e-06 | 9 | 84 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 TMEM63B HTR3C GRM7 CHRND | 1.13e-05 | 334 | 84 | 9 | GO:0022836 |
| GeneOntologyMolecularFunction | channel activity | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B HTR3C GRM7 CHRND | 1.23e-05 | 525 | 84 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.23e-05 | 34 | 84 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B HTR3C GRM7 CHRND | 1.25e-05 | 526 | 84 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.74e-05 | 129 | 84 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.89e-05 | 196 | 84 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.53e-05 | 14 | 84 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC22A18 SLCO1C1 SLC36A4 SLC35D2 SLCO1A2 ABCC11 SLCO1B3 SLC36A3 | 3.24e-05 | 293 | 84 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.23e-05 | 151 | 84 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 5.60e-05 | 18 | 84 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E TMC1 SLC24A4 TMEM63B SLC28A1 SLC36A3 GRM7 SLC29A1 | 6.22e-05 | 627 | 84 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 7.29e-05 | 53 | 84 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E TMC1 SLC24A4 TMEM63B SLC28A1 ABCC11 SLC36A3 GRM7 SLC29A1 | 7.55e-05 | 758 | 84 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 1.04e-04 | 4 | 84 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | cytidine transmembrane transporter activity | 1.04e-04 | 4 | 84 | 2 | GO:0015212 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 1.04e-04 | 4 | 84 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 1.04e-04 | 4 | 84 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 1.04e-04 | 4 | 84 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.11e-04 | 59 | 84 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A4 CACNA1A CACNA1B CACNA1E TMC1 SLC24A4 SLC28A1 GRM7 SLC29A1 | 1.46e-04 | 465 | 84 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.95e-04 | 27 | 84 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.40e-04 | 207 | 84 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.46e-04 | 208 | 84 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.54e-04 | 73 | 84 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | serotonin receptor activity | 2.59e-04 | 6 | 84 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 2.59e-04 | 6 | 84 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | taste receptor activity | 3.58e-04 | 33 | 84 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 3.62e-04 | 7 | 84 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 3.62e-04 | 7 | 84 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | peptide binding | 3.86e-04 | 318 | 84 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.16e-04 | 83 | 84 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.55e-04 | 152 | 84 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 4.82e-04 | 8 | 84 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 5.03e-04 | 37 | 84 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.66e-04 | 90 | 84 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 6.18e-04 | 9 | 84 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 6.18e-04 | 9 | 84 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 6.18e-04 | 9 | 84 | 2 | GO:0015349 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 6.18e-04 | 9 | 84 | 2 | GO:0015180 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 7.70e-04 | 10 | 84 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 7.70e-04 | 10 | 84 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 7.85e-04 | 43 | 84 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.41e-04 | 100 | 84 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 9.38e-04 | 11 | 84 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.03e-03 | 182 | 84 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.08e-03 | 184 | 84 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.60e-03 | 119 | 84 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.78e-03 | 57 | 84 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.97e-03 | 59 | 84 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 2.02e-03 | 16 | 84 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | odorant binding | 2.03e-03 | 127 | 84 | 4 | GO:0005549 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.07e-03 | 60 | 84 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.28e-03 | 17 | 84 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.56e-03 | 18 | 84 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.60e-03 | 65 | 84 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.60e-03 | 65 | 84 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.75e-03 | 138 | 84 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.89e-03 | 140 | 84 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 3.49e-03 | 21 | 84 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.90e-03 | 75 | 84 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 4.18e-03 | 23 | 84 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 4.18e-03 | 23 | 84 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.20e-03 | 77 | 84 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 4.54e-03 | 24 | 84 | 2 | GO:0019957 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.84e-03 | 81 | 84 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 5.32e-03 | 26 | 84 | 2 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 5.32e-03 | 26 | 84 | 2 | GO:0004950 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.73e-03 | 27 | 84 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.89e-03 | 171 | 84 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 8.20e-03 | 98 | 84 | 3 | GO:0048306 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 SLC24A4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 TAS2R30 OR2F1 OR2T11 GRM7 F2RL1 GRM8 NMS OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 8.16e-22 | 1395 | 83 | 37 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2W3 OR2F2 OR8J3 OR10A7 TMC1 SLC24A4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 PPEF1 OR2F1 OR2T11 GRM8 OR13J1 OR6X1 OR8G2P OR2A2 | 3.94e-18 | 582 | 83 | 24 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2W3 NPFFR2 OR2F2 OR8J3 OR10A7 TMC1 SLC24A4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 PPEF1 OR2F1 OR2T11 GRM8 OR13J1 OR6X1 OR8G2P OR2A2 | 4.25e-17 | 722 | 83 | 25 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR2W3 CACNA1E OR2F2 OR8J3 OR10A7 NPY1R TMC1 SLC24A4 OR11G2 WFS1 OR6C2 TAS2R33 TAS2R36 OR6J1 TMEM63B OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 PPEF1 OR2F1 OR2T11 GRM7 GRM8 OR13J1 OR6X1 OR8G2P OR2A2 | 5.13e-17 | 1072 | 83 | 29 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2W3 OR2F2 OR8J3 OR10A7 SLC24A4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 2.61e-16 | 485 | 83 | 21 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2W3 OR2F2 OR8J3 OR10A7 SLC24A4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 1.22e-15 | 524 | 83 | 21 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2W3 OR2F2 OR8J3 OR10A7 SLC24A4 OR11G2 OR6C2 TAS2R33 TAS2R36 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 2.86e-15 | 547 | 83 | 21 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2W3 OR2F2 OR8J3 OR10A7 SLC24A4 OR11G2 OR6C2 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 9.07e-14 | 432 | 83 | 18 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2W3 OR2F2 OR8J3 OR10A7 SLC24A4 OR11G2 OR6C2 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 3.17e-13 | 465 | 83 | 18 | GO:0007608 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A4 CACNA1A CACNA1B CACNA1E SLC22A18 CHRNA6 TMC1 SLCO1C1 SLC24A4 WFS1 SLCO1A2 TMEM63B ABCC11 SLCO1B3 NMUR1 SLC36A3 ATP11C HTR3C SLC22A17 CHRND | 3.69e-07 | 1374 | 83 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 6.80e-07 | 124 | 83 | 7 | GO:0007218 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | SLC6A4 CHRNA6 ADRA2B SLCO1C1 ABCA13 SLCO1A2 SLC44A2 MTTP ABCC11 SLCO1B3 | 1.73e-06 | 358 | 83 | 10 | GO:0015850 |
| GeneOntologyBiologicalProcess | organic cation transport | 1.95e-06 | 145 | 83 | 7 | GO:0015695 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R HTR4 HTR3C COLQ GRM7 GRM8 SLC29A1 CX3CR1 HCRTR1 CHRND | 4.03e-06 | 931 | 83 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R HTR4 HTR3C COLQ GRM7 GRM8 SLC29A1 CX3CR1 HCRTR1 CHRND | 4.03e-06 | 931 | 83 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R HTR4 HTR3C COLQ GRM7 GRM8 SLC29A1 CX3CR1 HCRTR1 CHRND | 4.47e-06 | 939 | 83 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R HTR4 HTR3C COLQ GRM7 GRM8 SLC29A1 CX3CR1 HCRTR1 CHRND | 7.13e-06 | 976 | 83 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 2.76e-05 | 15 | 83 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 2.93e-05 | 44 | 83 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 3.81e-05 | 47 | 83 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A SLCO1C1 SLC36A4 SLC35D2 SLCO1A2 ABCC11 SLCO1B3 SLC36A3 GRM7 | 3.98e-05 | 410 | 83 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A SLCO1C1 SLC36A4 SLC35D2 SLCO1A2 MTTP ABCC11 SLCO1B3 SLC36A3 GRM7 | 4.10e-05 | 515 | 83 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A SLCO1C1 SLC36A4 SLC35D2 SLCO1A2 ABCC11 SLCO1B3 SLC36A3 GRM7 | 4.13e-05 | 412 | 83 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 4.14e-05 | 48 | 83 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 4.14e-05 | 48 | 83 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 8.36e-05 | 259 | 83 | 7 | GO:0006836 | |
| GeneOntologyBiologicalProcess | cytidine transport | 9.55e-05 | 4 | 83 | 2 | GO:0015861 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 1.14e-04 | 118 | 83 | 5 | GO:0046928 | |
| GeneOntologyBiologicalProcess | amine transport | 2.30e-04 | 137 | 83 | 5 | GO:0015837 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside transport | 2.37e-04 | 6 | 83 | 2 | GO:0015864 | |
| GeneOntologyBiologicalProcess | uridine transmembrane transport | 2.37e-04 | 6 | 83 | 2 | GO:0015862 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 2.63e-04 | 141 | 83 | 5 | GO:0051588 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transport | 3.32e-04 | 7 | 83 | 2 | GO:0015855 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 3.32e-04 | 230 | 83 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | secretion | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R ADRA2B HTR4 TMEM63B MTTP GRM7 F2RL1 GRM8 SLC29A1 | 3.43e-04 | 1221 | 83 | 14 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 3.68e-04 | 84 | 83 | 4 | GO:0051480 | |
| GeneOntologyBiologicalProcess | nucleoside transmembrane transport | 4.41e-04 | 8 | 83 | 2 | GO:1901642 | |
| GeneOntologyBiologicalProcess | purine nucleobase transmembrane transport | 4.41e-04 | 8 | 83 | 2 | GO:1904823 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 4.73e-04 | 344 | 83 | 7 | GO:0003018 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 TMC1 SLC24A4 TMEM63B ABCC11 SLC36A3 ATP11C HTR3C CHRND | 4.88e-04 | 1115 | 83 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 5.65e-04 | 9 | 83 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | central nervous system maturation | 5.65e-04 | 9 | 83 | 2 | GO:0021626 | |
| GeneOntologyBiologicalProcess | calcium ion import | 6.61e-04 | 98 | 83 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | export from cell | SLC6A4 CACNA1A CACNA1B CACNA1E SLC22A18 CHRNA6 NPY1R ADRA2B SLC24A4 MTTP GRM7 F2RL1 GRM8 | 6.68e-04 | 1153 | 83 | 13 | GO:0140352 |
| GeneOntologyBiologicalProcess | nucleoside transport | 7.05e-04 | 10 | 83 | 2 | GO:0015858 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 7.39e-04 | 44 | 83 | 3 | GO:0001580 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R ADRA2B GRM7 F2RL1 GRM8 | 7.61e-04 | 740 | 83 | 10 | GO:1903530 |
| GeneOntologyBiologicalProcess | proline transmembrane transport | 8.59e-04 | 11 | 83 | 2 | GO:0035524 | |
| GeneOntologyBiologicalProcess | L-alanine transport | 8.59e-04 | 11 | 83 | 2 | GO:0015808 | |
| GeneOntologyBiologicalProcess | behavior | SLC6A4 CACNA1A CACNA1B CACNA1E NPY1R SLC24A4 WFS1 GRM7 NMS CX3CR1 HCRTR1 | 8.65e-04 | 891 | 83 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 9.54e-04 | 48 | 83 | 3 | GO:0050913 | |
| GeneOntologyBiologicalProcess | purine nucleobase transport | 1.03e-03 | 12 | 83 | 2 | GO:0006863 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.04e-03 | 286 | 83 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 1.07e-03 | 50 | 83 | 3 | GO:0050912 | |
| GeneOntologyBiologicalProcess | response to pain | 1.14e-03 | 51 | 83 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.15e-03 | 195 | 83 | 5 | GO:0099643 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.15e-03 | 195 | 83 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.15e-03 | 195 | 83 | 5 | GO:0007269 | |
| GeneOntologyBiologicalProcess | nucleobase transport | 1.21e-03 | 13 | 83 | 2 | GO:0015851 | |
| GeneOntologyBiologicalProcess | signal release | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R ADRA2B F2RL1 GRM8 | 1.23e-03 | 653 | 83 | 9 | GO:0023061 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R GRM7 GRM8 CX3CR1 | 1.37e-03 | 663 | 83 | 9 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R GRM7 GRM8 CX3CR1 | 1.38e-03 | 664 | 83 | 9 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of secretion | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 NPY1R ADRA2B GRM7 F2RL1 GRM8 | 1.38e-03 | 801 | 83 | 10 | GO:0051046 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A CMKLR2 CACNA1E NPY1R SLC24A4 WFS1 SLCO1A2 TMEM63B MTTP SLC29A1 SLC22A17 TMEM64 HCRTR1 | 1.39e-03 | 1249 | 83 | 13 | GO:0048878 |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.45e-03 | 121 | 83 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.63e-03 | 125 | 83 | 4 | GO:0016079 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.63e-03 | 125 | 83 | 4 | GO:0051952 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.68e-03 | 126 | 83 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound transmembrane transport | 1.85e-03 | 16 | 83 | 2 | GO:0072531 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 1.85e-03 | 16 | 83 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.88e-03 | 130 | 83 | 4 | GO:0060079 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 1.91e-03 | 61 | 83 | 3 | GO:0007187 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 2.05e-03 | 133 | 83 | 4 | GO:0007200 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.26e-04 | 277 | 84 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | vacuolar membrane | SLC36A4 ABCA13 SLC44A2 GPR137B ABCC11 SLC36A3 ATP11C SPPL2B SLC22A17 | 1.98e-04 | 507 | 84 | 9 | GO:0005774 |
| GeneOntologyCellularComponent | synaptic membrane | 5.50e-04 | 583 | 84 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 8.39e-04 | 46 | 84 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.22e-03 | 405 | 84 | 7 | GO:0045211 | |
| MousePheno | abnormal behavioral response to xenobiotic | SLC6A4 CACNA1A CACNA1B NPY1R HTR4 WFS1 MC2R GRM7 SLC29A1 HCRTR1 | 2.92e-07 | 309 | 55 | 10 | MP:0009745 |
| MousePheno | impaired behavioral response to alcohol | 6.78e-06 | 10 | 55 | 3 | MP:0009755 | |
| MousePheno | impaired behavioral response to xenobiotic | 1.80e-05 | 83 | 55 | 5 | MP:0009747 | |
| MousePheno | impaired behavioral response to addictive substance | 2.83e-05 | 45 | 55 | 4 | MP:0009750 | |
| MousePheno | abnormal physiological response to xenobiotic | FANCD2 SLC6A4 CACNA1A CACNA1E NPY1R HTR4 SLCO1B3 GRM7 F2RL1 GRM8 CX3CR1 | 4.40e-05 | 662 | 55 | 11 | MP:0008872 |
| MousePheno | abnormal hormone level | SLC6A4 CACNA1A CACNA1B NPFFR2 CMKLR2 CACNA1E NPY1R SLCO1C1 WFS1 MC2R MBOAT4 TMEM64 LCLAT1 CXCR2 | 4.99e-05 | 1073 | 55 | 14 | MP:0003953 |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 9.39e-05 | 117 | 55 | 5 | MP:0002906 | |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 9.78e-05 | 118 | 55 | 5 | MP:0012349 | |
| MousePheno | abnormal behavioral response to alcohol | 1.10e-04 | 24 | 55 | 3 | MP:0020157 | |
| MousePheno | abnormal seizure response to pharmacological agent | 2.74e-04 | 147 | 55 | 5 | MP:0000950 | |
| MousePheno | abnormal channel response | 2.89e-04 | 33 | 55 | 3 | MP:0003484 | |
| MousePheno | abnormal alcohol consumption | 3.45e-04 | 35 | 55 | 3 | MP:0001425 | |
| Domain | 7tm_1 | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 OR6J1 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 OR2F1 OR2T11 F2RL1 OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 1.82e-22 | 677 | 83 | 30 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 OR6J1 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 OR2F1 OR2T11 F2RL1 OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 2.55e-22 | 685 | 83 | 30 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 OR6J1 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 OR2F1 OR2T11 F2RL1 OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 3.28e-22 | 691 | 83 | 30 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 OR6J1 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 OR2F1 OR2T11 F2RL1 OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 3.42e-22 | 692 | 83 | 30 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR2W3 NPFFR2 CMKLR2 OR2F2 OR8J3 OR10A7 NPY1R ADRA2B HTR4 OR11G2 OR6C2 HCAR1 MC2R OR5B21 OR1L6 GPR135 OR14I1 NMUR1 OR4D11 OR2F1 OR2T11 F2RL1 OR13J1 OR6X1 CX3CR1 HCRTR1 CXCR2 OR8G2P OR2A2 | 2.11e-21 | 670 | 83 | 29 | IPR017452 |
| Domain | Olfact_rcpt | OR2W3 OR2F2 OR8J3 OR10A7 OR11G2 OR6C2 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 1.26e-12 | 393 | 83 | 17 | IPR000725 |
| Domain | MFS_dom | 2.21e-06 | 134 | 83 | 7 | IPR020846 | |
| Domain | GPHH_dom | 2.92e-06 | 7 | 83 | 3 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 2.92e-06 | 7 | 83 | 3 | IPR014873 | |
| Domain | Ca_chan_IQ | 2.92e-06 | 7 | 83 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.92e-06 | 7 | 83 | 3 | PF08763 | |
| Domain | GPHH | 2.92e-06 | 7 | 83 | 3 | PF16905 | |
| Domain | VDCCAlpha1 | 9.93e-06 | 10 | 83 | 3 | IPR002077 | |
| Domain | 7TM_GPCR_Srsx | 1.05e-05 | 112 | 83 | 6 | SM01381 | |
| Domain | OA_transporter | 1.81e-05 | 12 | 83 | 3 | IPR004156 | |
| Domain | OATP | 1.81e-05 | 12 | 83 | 3 | PF03137 | |
| Domain | MFS | 1.20e-04 | 108 | 83 | 5 | PS50850 | |
| Domain | Acetylcholine_rcpt_TM | 1.41e-04 | 23 | 83 | 3 | IPR027361 | |
| Domain | - | 1.41e-04 | 23 | 83 | 3 | 1.20.120.370 | |
| Domain | CXCR4/ACKR2 | 4.04e-04 | 7 | 83 | 2 | IPR001277 | |
| Domain | GPCR_3_mtglu_rcpt | 5.37e-04 | 8 | 83 | 2 | IPR000162 | |
| Domain | Kazal_2 | 5.44e-04 | 36 | 83 | 3 | PF07648 | |
| Domain | ADR_fam | 8.58e-04 | 10 | 83 | 2 | IPR002233 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.05e-03 | 45 | 83 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.12e-03 | 46 | 83 | 3 | PF02932 | |
| Domain | KAZAL | 1.12e-03 | 46 | 83 | 3 | SM00280 | |
| Domain | Neur_chan_LBD | 1.19e-03 | 47 | 83 | 3 | PF02931 | |
| Domain | Neur_channel | 1.19e-03 | 47 | 83 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.19e-03 | 47 | 83 | 3 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 1.19e-03 | 47 | 83 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.19e-03 | 47 | 83 | 3 | IPR006029 | |
| Domain | - | 1.19e-03 | 47 | 83 | 3 | 2.70.170.10 | |
| Domain | KAZAL_2 | 1.43e-03 | 50 | 83 | 3 | PS51465 | |
| Domain | NCD3G | 1.47e-03 | 13 | 83 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.47e-03 | 13 | 83 | 2 | IPR011500 | |
| Domain | Kazal_dom | 1.51e-03 | 51 | 83 | 3 | IPR002350 | |
| Domain | GPCR_3_CS | 1.72e-03 | 14 | 83 | 2 | IPR017979 | |
| Domain | Channel_four-helix_dom | 2.08e-03 | 57 | 83 | 3 | IPR027359 | |
| Domain | - | 2.08e-03 | 57 | 83 | 3 | 1.20.120.350 | |
| Domain | Nicotinic_acetylcholine_rcpt | 2.25e-03 | 16 | 83 | 2 | IPR002394 | |
| Domain | Aa_trans | 2.54e-03 | 17 | 83 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 2.54e-03 | 17 | 83 | 2 | IPR013057 | |
| Domain | GPCR_3 | 3.88e-03 | 21 | 83 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 4.25e-03 | 22 | 83 | 2 | PS50259 | |
| Domain | 7tm_3 | 4.25e-03 | 22 | 83 | 2 | PF00003 | |
| Domain | GPCR_3_C | 4.25e-03 | 22 | 83 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 4.25e-03 | 22 | 83 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 4.25e-03 | 22 | 83 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 4.25e-03 | 22 | 83 | 2 | PS00979 | |
| Domain | FYVE | 7.33e-03 | 29 | 83 | 2 | PF01363 | |
| Domain | FYVE | 7.33e-03 | 29 | 83 | 2 | SM00064 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPFFR2 CMKLR2 OR2F2 NPY1R ADRA2B HTR4 HCAR1 MC2R NMUR1 OR2F1 F2RL1 CX3CR1 HCRTR1 CXCR2 | 4.28e-11 | 260 | 72 | 14 | M39397 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR2W3 OR2F2 OR8J3 OR10A7 OR11G2 OR6C2 OR5B21 OR1L6 OR14I1 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 8.36e-11 | 389 | 72 | 16 | M14091 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2W3 OR2F2 OR8J3 OR10A7 OR11G2 OR6C2 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR2A2 | 2.33e-10 | 417 | 72 | 16 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2W3 OR2F2 OR8J3 OR10A7 TMC1 OR11G2 OR6C2 OR6J1 OR5B21 OR1L6 OR14I1 OR4D11 TAS2R30 PPEF1 OR2F1 OR2T11 OR13J1 OR6X1 OR2A2 | 2.59e-10 | 636 | 72 | 19 | M41834 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPFFR2 NPY1R ADRA2B HTR4 HCAR1 MC2R NMUR1 TAS2R30 GRM7 F2RL1 PLPPR1 GRM8 NMS CX3CR1 HCRTR1 CXCR2 | 3.66e-10 | 430 | 72 | 16 | MM15160 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPFFR2 NPY1R ADRA2B HTR4 HCAR1 MC2R NMUR1 TAS2R30 GRM7 F2RL1 PLPPR1 GRM8 NMS CX3CR1 HCRTR1 CXCR2 | 1.07e-09 | 463 | 72 | 16 | M507 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPFFR2 NPY1R ADRA2B HTR4 FGD2 FGD4 HCAR1 MC2R NMUR1 TAS2R30 GRM7 F2RL1 PLPPR1 GRM8 NMS CX3CR1 HCRTR1 CXCR2 | 2.55e-09 | 646 | 72 | 18 | MM14962 |
| Pathway | WP_GPCRS_NONODORANT | NPFFR2 NPY1R ADRA2B HTR4 MC2R NMUR1 GRM7 F2RL1 GRM8 CX3CR1 HCRTR1 CXCR2 | 8.94e-09 | 266 | 72 | 12 | MM15843 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPFFR2 NPY1R ADRA2B HTR4 FGD2 FGD4 HCAR1 MC2R NMUR1 TAS2R30 GRM7 F2RL1 PLPPR1 GRM8 NMS CX3CR1 HCRTR1 CXCR2 | 9.41e-09 | 702 | 72 | 18 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | NPFFR2 NPY1R ADRA2B HTR4 HCAR1 MC2R NMUR1 F2RL1 PLPPR1 NMS CX3CR1 HCRTR1 CXCR2 | 1.03e-08 | 330 | 72 | 13 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | NPFFR2 NPY1R ADRA2B HTR4 HCAR1 MC2R NMUR1 F2RL1 PLPPR1 NMS CX3CR1 HCRTR1 CXCR2 | 1.14e-08 | 333 | 72 | 13 | MM14963 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | NPFFR2 CHRNA6 NPY1R ADRA2B HTR4 MC2R NMUR1 GRM7 F2RL1 GRM8 HCRTR1 CHRND | 1.15e-08 | 272 | 72 | 12 | M13380 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPY1R ADRA2B HTR4 MC2R NMUR1 F2RL1 OR13J1 CX3CR1 CXCR2 OR8G2P | 3.31e-08 | 186 | 72 | 10 | MM15994 |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 5.60e-08 | 41 | 72 | 6 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 7.54e-08 | 43 | 72 | 6 | M881 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 SLCO1A2 SLC44A2 SLC28A1 SLCO1B3 SLC29A1 | 3.34e-07 | 238 | 72 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 SLCO1A2 SLC44A2 SLC28A1 SLCO1B3 SLC29A1 | 5.06e-07 | 249 | 72 | 10 | M5988 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 6.74e-07 | 197 | 72 | 9 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 6.74e-07 | 197 | 72 | 9 | MM14970 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.96e-06 | 289 | 72 | 10 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.11e-06 | 314 | 72 | 10 | M600 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 SLCO1A2 SLC44A2 SLC28A1 MTTP ABCC11 SLCO1B3 ATP11C SLC29A1 SLC22A17 | 1.76e-05 | 736 | 72 | 14 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 2.05e-05 | 11 | 72 | 3 | M930 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.05e-05 | 11 | 72 | 3 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.05e-05 | 11 | 72 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.05e-05 | 11 | 72 | 3 | M26913 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 2.72e-05 | 12 | 72 | 3 | MM15476 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 SLCO1A2 SLC44A2 SLC28A1 MTTP SLCO1B3 ATP11C SLC29A1 SLC22A17 | 3.53e-05 | 681 | 72 | 13 | MM14985 |
| Pathway | WP_PEPTIDE_GPCRS | 3.95e-05 | 75 | 72 | 5 | M39696 | |
| Pathway | WP_GPCRS_OTHER | 1.11e-04 | 93 | 72 | 5 | M39629 | |
| Pathway | WP_GPCRS_ODORANT | 1.48e-04 | 157 | 72 | 6 | MM15872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.10e-04 | 23 | 72 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.71e-04 | 25 | 72 | 3 | M47948 | |
| Pathway | WP_GPCRS_PEPTIDE | 4.45e-04 | 70 | 72 | 4 | MM15959 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.46e-04 | 270 | 72 | 7 | M15514 | |
| Pathway | REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS | 7.06e-04 | 8 | 72 | 2 | M27291 | |
| Pathway | REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS | 7.06e-04 | 8 | 72 | 2 | MM14995 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 7.19e-04 | 211 | 72 | 6 | MM14502 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 8.76e-04 | 37 | 72 | 3 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.02e-03 | 39 | 72 | 3 | M793 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.37e-03 | 11 | 72 | 2 | MM15471 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.64e-03 | 12 | 72 | 2 | M27728 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.64e-03 | 12 | 72 | 2 | M48008 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.76e-03 | 47 | 72 | 3 | M19708 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 2.23e-03 | 51 | 72 | 3 | M39457 | |
| Pathway | WP_SULFATASE_AND_AROMATASE_PATHWAY | 2.25e-03 | 14 | 72 | 2 | M48085 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.25e-03 | 14 | 72 | 2 | M757 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.59e-03 | 15 | 72 | 2 | M39442 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.59e-03 | 15 | 72 | 2 | MM14704 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.59e-03 | 15 | 72 | 2 | MM15845 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.85e-03 | 190 | 72 | 5 | MM15687 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 3.73e-03 | 18 | 72 | 2 | M4862 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 4.16e-03 | 19 | 72 | 2 | MM14612 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 4.36e-03 | 210 | 72 | 5 | MM15043 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.91e-03 | 411 | 72 | 7 | M735 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 5.01e-03 | 217 | 72 | 5 | M18437 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 5.47e-03 | 70 | 72 | 3 | MM14984 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2W3 OR2F2 OR8J3 OR11G2 OR6C2 OR5B21 OR1L6 OR4D11 OR2F1 OR13J1 OR6X1 OR8G2P OR2A2 | 2.33e-12 | 340 | 85 | 13 | 11875048 |
| Pubmed | OR2W3 OR2F2 OR8J3 OR11G2 OR6C2 OR5B21 OR1L6 OR4D11 OR2F1 OR13J1 OR6X1 OR8G2P OR2A2 | 2.33e-12 | 340 | 85 | 13 | 11802173 | |
| Pubmed | OR2W3 OR2F2 OR8J3 OR11G2 OR6C2 OR5B21 OR1L6 OR4D11 OR2F1 OR13J1 OR6X1 OR8G2P OR2A2 | 2.60e-12 | 343 | 85 | 13 | 32295537 | |
| Pubmed | OR2W3 OR2F2 OR8J3 OR11G2 OR6C2 OR5B21 OR1L6 OR4D11 OR2F1 OR13J1 OR6X1 OR8G2P OR2A2 | 2.90e-12 | 346 | 85 | 13 | 14611657 | |
| Pubmed | OR2W3 OR2F2 OR8J3 OR10A7 OR11G2 OR1L6 OR4D11 OR2F1 OR2T11 OR13J1 OR6X1 OR8G2P OR2A2 | 7.20e-10 | 541 | 85 | 13 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 3.59e-09 | 219 | 85 | 9 | 12213199 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.41e-08 | 3 | 85 | 3 | 24523520 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 5.63e-08 | 4 | 85 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 5.63e-08 | 4 | 85 | 3 | 37141091 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 8825650 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 25765938 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 15451373 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 11296258 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 2.80e-07 | 6 | 85 | 3 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.80e-07 | 6 | 85 | 3 | 12827191 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 9238069 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 4.90e-07 | 7 | 85 | 3 | 35176221 | |
| Pubmed | Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. | 7.82e-07 | 8 | 85 | 3 | 19129463 | |
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 16382099 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 14579113 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30847922 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 5.90e-06 | 2 | 85 | 2 | 23426690 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16381801 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23220400 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11912074 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26655190 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20007481 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22644860 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28924232 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23376566 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20734919 | ||
| Pubmed | 5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humans. | 5.90e-06 | 2 | 85 | 2 | 22584237 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12097333 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 38155373 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 5.90e-06 | 2 | 85 | 2 | 12074836 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 32312148 | ||
| Pubmed | Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology. | 5.90e-06 | 2 | 85 | 2 | 23664812 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27072889 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21854681 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18600541 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15050706 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21143597 | ||
| Pubmed | 6.28e-06 | 15 | 85 | 3 | 20188150 | ||
| Pubmed | 6.28e-06 | 15 | 85 | 3 | 24453333 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.09e-05 | 118 | 85 | 5 | 19156168 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.62e-05 | 128 | 85 | 5 | 19058789 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29466725 | ||
| Pubmed | Postnatal ontogeny of Neuromedin S and its receptors NMUR1 and NMUR2 expression in mouse testis. | 1.77e-05 | 3 | 85 | 2 | 36336170 | |
| Pubmed | Resequencing three candidate genes for major depressive disorder in a Dutch cohort. | 1.77e-05 | 3 | 85 | 2 | 24278217 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 1.77e-05 | 3 | 85 | 2 | 24394417 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19890249 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20051929 | ||
| Pubmed | Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel. | 1.77e-05 | 3 | 85 | 2 | 24825069 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 33068816 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20560925 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22203093 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9473604 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.77e-05 | 3 | 85 | 2 | 29208674 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 1.77e-05 | 3 | 85 | 2 | 26507659 | |
| Pubmed | Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors. | 1.77e-05 | 3 | 85 | 2 | 15386342 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20060867 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10779507 | ||
| Pubmed | 1.82e-05 | 21 | 85 | 3 | 15452121 | ||
| Pubmed | Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. | 3.53e-05 | 4 | 85 | 2 | 22294745 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 26283199 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17509016 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 11818437 | ||
| Pubmed | Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. | 3.53e-05 | 4 | 85 | 2 | 15635449 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 20644253 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15728831 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21849517 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18347198 | ||
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 3.53e-05 | 4 | 85 | 2 | 25483588 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 31253182 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 10899166 | ||
| Pubmed | Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy. | 3.53e-05 | 4 | 85 | 2 | 33247179 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18635603 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17564959 | ||
| Pubmed | Distribution of group-III metabotropic glutamate receptors in the retina. | 3.53e-05 | 4 | 85 | 2 | 17311335 | |
| Pubmed | Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. | 3.53e-05 | 4 | 85 | 2 | 31039135 | |
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 3.53e-05 | 4 | 85 | 2 | 15953418 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17167337 | ||
| Pubmed | Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance. | 3.53e-05 | 4 | 85 | 2 | 27777271 | |
| Pubmed | 4.42e-05 | 28 | 85 | 3 | 19352218 | ||
| Pubmed | Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction. | 5.87e-05 | 5 | 85 | 2 | 19494266 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 17926640 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 20665488 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 16787652 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 24194565 | ||
| Pubmed | Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. | 5.87e-05 | 5 | 85 | 2 | 19109198 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 32937134 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 20635135 | ||
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 8.80e-05 | 6 | 85 | 2 | 16144832 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 22232210 | ||
| Pubmed | Characterization of serotonin neurotransmission in knockout mice: implications for major depression. | 8.80e-05 | 6 | 85 | 2 | 23089640 | |
| Pubmed | Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. | 8.80e-05 | 6 | 85 | 2 | 17672867 | |
| Pubmed | Cortical RORβ is required for layer 4 transcriptional identity and barrel integrity. | 8.80e-05 | 6 | 85 | 2 | 32851975 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 10328888 | ||
| Interaction | SIDT2 interactions | 3.65e-08 | 140 | 72 | 8 | int:SIDT2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 5.50e-05 | 113 | 83 | 4 | chr12p12 | |
| Cytoband | 7q35 | 1.40e-04 | 55 | 83 | 3 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 2.40e-04 | 66 | 83 | 3 | chr7q35 | |
| Cytoband | 12p12 | 2.49e-04 | 13 | 83 | 2 | 12p12 | |
| Cytoband | 1q44 | 1.07e-03 | 110 | 83 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 1.65e-03 | 128 | 83 | 3 | chr1q44 | |
| Cytoband | 11q12.1 | 3.17e-03 | 161 | 83 | 3 | 11q12.1 | |
| Cytoband | 14q23.1 | 3.31e-03 | 47 | 83 | 2 | 14q23.1 | |
| Cytoband | 14q11.2 | 4.33e-03 | 180 | 83 | 3 | 14q11.2 | |
| Cytoband | 12q13.2 | 4.51e-03 | 55 | 83 | 2 | 12q13.2 | |
| GeneFamily | Solute carriers | SLC6A4 SLC22A18 SLCO1C1 SLC24A4 SLC36A4 SLC35D2 SLCO1A2 SLC44A2 SLC28A1 SLC15A5 SLCO1B3 SLC36A3 SLC35F2 SLC29A1 SLC22A17 | 2.84e-11 | 395 | 71 | 15 | 752 |
| GeneFamily | Olfactory receptors, family 2 | 8.18e-05 | 113 | 71 | 5 | 149 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.41e-04 | 26 | 71 | 3 | 253 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 4.19e-04 | 8 | 71 | 2 | 281 | |
| GeneFamily | Taste 2 receptors | 4.79e-04 | 39 | 71 | 3 | 1162 | |
| GeneFamily | Neuropeptide receptors | 6.70e-04 | 10 | 71 | 2 | 854 | |
| GeneFamily | Olfactory receptors, family 6 | 1.06e-03 | 51 | 71 | 3 | 153 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.76e-03 | 16 | 71 | 2 | 173 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 6.57e-03 | 31 | 71 | 2 | 81 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-05 | 161 | 83 | 5 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 161 | 83 | 5 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 167 | 83 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-05 | 167 | 83 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 169 | 83 | 5 | 7c994653b0d629dfb046755d6b678452de0a15d2 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 82 | 83 | 4 | ea3bdd7b871269eacb81167c6cf59a0e21bf6d83 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 82 | 83 | 4 | 72d5a55ca7c03e9c54f865524e206b288f242017 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 82 | 83 | 4 | e500582511814a067852dc3bd78d19937c28ba60 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 171 | 83 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 171 | 83 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 180 | 83 | 5 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 180 | 83 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 180 | 83 | 5 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | 2.31e-05 | 182 | 83 | 5 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 3.21e-05 | 195 | 83 | 5 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 3.21e-05 | 195 | 83 | 5 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-05 | 200 | 83 | 5 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.17e-05 | 109 | 83 | 4 | 4e4a884b8979f4ff8b232c1581ea78884dda29ed | |
| Computational | Genes in the cancer module 146. | 4.59e-08 | 102 | 37 | 7 | MODULE_146 | |
| Computational | GPCR signaling pathways (immune and neuro). | 5.49e-07 | 90 | 37 | 6 | MODULE_375 | |
| Computational | Genes in the cancer module 289. | 3.62e-06 | 124 | 37 | 6 | MODULE_289 | |
| Computational | Genes in the cancer module 134. | 1.43e-04 | 30 | 37 | 3 | MODULE_134 | |
| Computational | Genes in the cancer module 288. | 2.69e-04 | 37 | 37 | 3 | MODULE_288 | |
| Computational | Neighborhood of LMO1 | 7.39e-04 | 52 | 37 | 3 | MORF_LMO1 | |
| Drug | AC 110 | 1.80e-07 | 4 | 82 | 3 | CID000022860 | |
| Drug | Fk 888 | 4.10e-07 | 42 | 82 | 5 | CID000107967 | |
| Drug | 3,4-dihydroquinazoline | 8.94e-07 | 6 | 82 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 8.94e-07 | 6 | 82 | 3 | CID000133976 | |
| Drug | alpha-conotoxin SI | 1.31e-06 | 23 | 82 | 4 | CID000163979 | |
| Drug | APMPA | 1.56e-06 | 7 | 82 | 3 | CID000512300 | |
| Drug | nefiracetam | 1.77e-06 | 56 | 82 | 5 | CID000071157 | |
| Drug | tetradotoxin | CACNA1A CACNA1B CACNA1E CHRNA6 ADRA2B HTR4 GRM7 F2RL1 GRM8 CHRND | 3.18e-06 | 428 | 82 | 10 | CID000020382 |
| Drug | DCG-IV | 4.67e-06 | 68 | 82 | 5 | CID000115114 | |
| Drug | fluspirilene | 6.67e-06 | 34 | 82 | 4 | CID000003396 | |
| Drug | leys | 7.28e-06 | 11 | 82 | 3 | CID000484683 | |
| Drug | AC1L2VU3 | 9.68e-06 | 12 | 82 | 3 | CID000129572 | |
| Drug | 3,4-diaminopyridine | 1.05e-05 | 38 | 82 | 4 | CID000005918 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 1.17e-05 | 39 | 82 | 4 | CID003331970 | |
| Drug | norcepharadione B | 1.28e-05 | 2 | 82 | 2 | CID000189168 | |
| Drug | aristolactam AII | 1.28e-05 | 2 | 82 | 2 | CID000148657 | |
| Drug | alkosin | 1.28e-05 | 2 | 82 | 2 | CID005488638 | |
| Drug | piperolactam A | 1.28e-05 | 2 | 82 | 2 | CID003081016 | |
| Drug | brimonidine | 1.48e-05 | 86 | 82 | 5 | CID000002435 | |
| Drug | hexachlorophene | 1.85e-05 | 90 | 82 | 5 | CID000003598 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.95e-05 | 91 | 82 | 5 | CID000002207 | |
| Drug | butamben | 1.99e-05 | 15 | 82 | 3 | CID000002482 | |
| Drug | Nicorette | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 HTR4 GRM7 GRM8 CHRND CXCR2 | 2.01e-05 | 529 | 82 | 10 | CID000000942 |
| Drug | pentasulfane | 2.44e-05 | 16 | 82 | 3 | CID000448216 | |
| Drug | Verapamil | 2.44e-05 | 16 | 82 | 3 | DB00661 | |
| Drug | NSC755875 | 2.94e-05 | 165 | 82 | 6 | CID000002215 | |
| Drug | loperamide | 3.90e-05 | 105 | 82 | 5 | CID000003954 | |
| Drug | 5-fluorodeoxyuridine | 4.08e-05 | 106 | 82 | 5 | CID000003363 | |
| Drug | N6-Me-dAdo | 4.19e-05 | 19 | 82 | 3 | CID000168948 | |
| Drug | pranidipine | 4.19e-05 | 19 | 82 | 3 | CID006436048 | |
| Drug | aminocyclopentane | 4.19e-05 | 19 | 82 | 3 | CID000002906 | |
| Drug | acetylcholine | 4.75e-05 | 361 | 82 | 8 | CID000000187 | |
| Drug | amsonine | 4.93e-05 | 181 | 82 | 6 | CID000002866 | |
| Drug | dopamine | SLC6A4 CACNA1A CACNA1B CACNA1E CHRNA6 ADRA2B HTR4 GRM7 GRM8 SLC29A1 CHRND | 5.00e-05 | 715 | 82 | 11 | CID000000681 |
| Drug | gamma-aminobutyric acid | 5.20e-05 | 474 | 82 | 9 | CID000000119 | |
| Drug | guanethidine | 5.54e-05 | 113 | 82 | 5 | CID000003518 | |
| Drug | SR 48968 | 5.72e-05 | 58 | 82 | 4 | CID000104974 | |
| Drug | morphine hydrochloride | CACNA1A CACNA1B NPFFR2 CACNA1E SLC22A18 GRM7 GRM8 CX3CR1 CXCR2 | 5.82e-05 | 481 | 82 | 9 | CID000004253 |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 7.04e-05 | 193 | 82 | 6 | 6189_UP | |
| Drug | EGTA-AM | 7.44e-05 | 62 | 82 | 4 | CID000121907 | |
| Drug | LY320135 | 7.57e-05 | 23 | 82 | 3 | CID005311257 | |
| Drug | ABT-418 | 7.57e-05 | 23 | 82 | 3 | CID000119380 | |
| Drug | Dihydromicrocystin Lr | 7.65e-05 | 4 | 82 | 2 | CID006441227 | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 3683_UP | |
| Drug | PrBCM | 9.78e-05 | 25 | 82 | 3 | CID000037396 | |
| Drug | sodium glycocholate | 1.13e-04 | 69 | 82 | 4 | CID000000755 | |
| Drug | mAHP | 1.24e-04 | 27 | 82 | 3 | CID000220531 | |
| Drug | eniluracil | 1.24e-04 | 27 | 82 | 3 | CID000043157 | |
| Drug | almagel | 1.27e-04 | 5 | 82 | 2 | CID003080942 | |
| Drug | S 8510 | 1.27e-04 | 5 | 82 | 2 | CID005488383 | |
| Drug | Barium | 1.33e-04 | 72 | 82 | 4 | ctd:D001464 | |
| Drug | Virginiamycin S1 | 1.38e-04 | 28 | 82 | 3 | CID000122731 | |
| Drug | AC1L1KC5 | 1.42e-04 | 541 | 82 | 9 | CID000005428 | |
| Drug | 1,3-dipropylxanthine | 1.48e-04 | 74 | 82 | 4 | CID000169317 | |
| Drug | myo-inositol | CACNA1A CACNA1B CMKLR2 CACNA1E CHRNA6 ADRA2B HTR4 HCAR1 GRM7 GRM8 CHRND | 1.53e-04 | 811 | 82 | 11 | CID000000892 |
| Drug | glufosinate | 1.65e-04 | 76 | 82 | 4 | CID000004794 | |
| Drug | BAPTA | 1.69e-04 | 324 | 82 | 7 | CID000104751 | |
| Drug | muscarine | 1.74e-04 | 144 | 82 | 5 | CID000009308 | |
| Drug | carbachol | CACNA1A CACNA1B NPFFR2 CACNA1E CHRNA6 ADRA2B HTR4 GRM7 GRM8 CHRND | 1.79e-04 | 688 | 82 | 10 | CID000002551 |
| Drug | Dantrolene-13C3 | 1.80e-04 | 145 | 82 | 5 | CID000002951 | |
| Drug | nimodipine | 1.80e-04 | 145 | 82 | 5 | CID000004497 | |
| Drug | nicardipine | 1.80e-04 | 145 | 82 | 5 | CID000004473 | |
| Drug | hemicholinium-3 | 1.82e-04 | 78 | 82 | 4 | CID000003585 | |
| Drug | trospium chloride | 1.90e-04 | 6 | 82 | 2 | ctd:C003330 | |
| Drug | prednisolone phosphate | 1.90e-04 | 6 | 82 | 2 | CID000004896 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.97e-04 | 233 | 82 | 6 | CID000005114 | |
| Drug | AC1L1KS5 | 2.03e-04 | 334 | 82 | 7 | CID000005631 | |
| Drug | 17beta-estradiol glucuronide | 2.07e-04 | 32 | 82 | 3 | CID000066424 | |
| Drug | 3-aminopropylphosphinic acid | 2.07e-04 | 32 | 82 | 3 | CID006335948 | |
| Drug | pseudococaine | 2.10e-04 | 570 | 82 | 9 | CID000002826 | |
| Drug | A61603 | 2.27e-04 | 33 | 82 | 3 | CID004038180 | |
| Drug | CNS 1145 | 2.27e-04 | 33 | 82 | 3 | CID000190902 | |
| Drug | IHC-64 | 2.27e-04 | 33 | 82 | 3 | CID000162753 | |
| Drug | GF109203X | 2.31e-04 | 341 | 82 | 7 | CID000002396 | |
| Drug | procaine | 2.31e-04 | 153 | 82 | 5 | CID000004914 | |
| Drug | Substance P | 2.39e-04 | 343 | 82 | 7 | CID000036511 | |
| Drug | capsazepine | 2.42e-04 | 84 | 82 | 4 | CID002733484 | |
| Drug | XeC compound | 2.42e-04 | 84 | 82 | 4 | CID000005701 | |
| Drug | Cytidine | 2.66e-04 | 7 | 82 | 2 | ctd:D003562 | |
| Drug | demethylphalloin | 2.66e-04 | 7 | 82 | 2 | CID000114793 | |
| Drug | IPSP | 2.77e-04 | 87 | 82 | 4 | CID000022083 | |
| Drug | 3-7a | 2.95e-04 | 36 | 82 | 3 | CID011987860 | |
| Drug | CP-80 | 2.95e-04 | 36 | 82 | 3 | CID000452640 | |
| Drug | bethanechol | 3.16e-04 | 90 | 82 | 4 | CID000002370 | |
| Drug | sipatrigine | 3.20e-04 | 37 | 82 | 3 | CID000060803 | |
| Drug | DAPs | 3.43e-04 | 92 | 82 | 4 | CID000146339 | |
| Drug | 8-cyclopentyltheophylline | 3.47e-04 | 38 | 82 | 3 | CID000001917 | |
| Drug | 3,5-diiodo-L-thyronine | 3.47e-04 | 38 | 82 | 3 | CID000092859 | |
| Drug | cis-MCG-I | 3.54e-04 | 8 | 82 | 2 | CID003035584 | |
| Drug | NSC263652 | 3.54e-04 | 8 | 82 | 2 | CID000429721 | |
| Drug | Prestwick_523 | 3.75e-04 | 39 | 82 | 3 | CID000003687 | |
| Drug | verapamil | 3.84e-04 | 490 | 82 | 8 | CID000002520 | |
| Drug | epps | 4.04e-04 | 40 | 82 | 3 | CID000085255 | |
| Drug | riluzole | 4.18e-04 | 174 | 82 | 5 | CID000005070 | |
| Drug | BMY 7378 | 4.35e-04 | 41 | 82 | 3 | CID000002419 | |
| Drug | AC1L1I54 | 4.35e-04 | 41 | 82 | 3 | CID000004426 | |
| Drug | AC1N21PP | 4.54e-04 | 9 | 82 | 2 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 4.54e-04 | 9 | 82 | 2 | CID000107216 | |
| Drug | pozanicline | 4.54e-04 | 9 | 82 | 2 | ctd:C108326 | |
| Drug | mM PEP | 4.54e-04 | 9 | 82 | 2 | CID005311462 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.58e-08 | 3 | 75 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 6.30e-08 | 4 | 75 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | SLC6A4 CACNA1A CACNA1B CHRNA6 THSD7A HTR4 ABCA13 WFS1 MC2R GRM7 | 3.60e-07 | 477 | 75 | 10 | C0005586 |
| Disease | hereditary ataxia (implicated_via_orthology) | 5.48e-07 | 7 | 75 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Depressive disorder | 7.35e-07 | 289 | 75 | 8 | C0011581 | |
| Disease | Mental Depression | 3.89e-06 | 254 | 75 | 7 | C0011570 | |
| Disease | Charcot-Marie-Tooth disease type 4H (implicated_via_orthology) | 3.81e-05 | 4 | 75 | 2 | DOID:0110192 (implicated_via_orthology) | |
| Disease | X-linked Aarskog syndrome (implicated_via_orthology) | 3.81e-05 | 4 | 75 | 2 | DOID:6683 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 6.11e-05 | 163 | 75 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 9.50e-05 | 6 | 75 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | Anxiety States, Neurotic | 1.94e-04 | 44 | 75 | 3 | C0376280 | |
| Disease | Anxiety Disorders | 1.94e-04 | 44 | 75 | 3 | C0003469 | |
| Disease | Anxiety neurosis (finding) | 1.94e-04 | 44 | 75 | 3 | C1279420 | |
| Disease | response to topoisomerase inhibitor, response to antineoplastic agent | 2.27e-04 | 9 | 75 | 2 | GO_0072758, GO_0097327 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 2.27e-04 | 9 | 75 | 2 | EFO_0800562 | |
| Disease | X-21467 measurement | 2.27e-04 | 9 | 75 | 2 | EFO_0020007 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.45e-04 | 11 | 75 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | ecosanoids measurement | 3.76e-04 | 55 | 75 | 3 | EFO_0020044 | |
| Disease | Withdrawal Symptoms | 4.40e-04 | 58 | 75 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 4.40e-04 | 58 | 75 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 4.40e-04 | 58 | 75 | 3 | C0038587 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 4.88e-04 | 13 | 75 | 2 | EFO_0800474 | |
| Disease | Alcoholic Intoxication, Chronic | 6.12e-04 | 268 | 75 | 5 | C0001973 | |
| Disease | Rolandic epilepsy | 7.48e-04 | 16 | 75 | 2 | Orphanet_1945 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 7.48e-04 | 16 | 75 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Mood Disorders | 9.00e-04 | 168 | 75 | 4 | C0525045 | |
| Disease | daytime rest measurement | 9.41e-04 | 295 | 75 | 5 | EFO_0007828 | |
| Disease | borna disease (biomarker_via_orthology) | 9.50e-04 | 18 | 75 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 1.18e-03 | 20 | 75 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | Attention Deficit Disorder | 1.42e-03 | 22 | 75 | 2 | C0041671 | |
| Disease | depressive disorder (implicated_via_orthology) | 1.42e-03 | 22 | 75 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | Minimal Brain Dysfunction | 1.42e-03 | 22 | 75 | 2 | C1321905 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.42e-03 | 22 | 75 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | obesity (is_implicated_in) | 1.63e-03 | 91 | 75 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 1.70e-03 | 24 | 75 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital | 1.70e-03 | 24 | 75 | 2 | C0751882 | |
| Disease | Attention deficit hyperactivity disorder | 1.70e-03 | 24 | 75 | 2 | C1263846 | |
| Disease | Schizophrenia | 1.79e-03 | 883 | 75 | 8 | C0036341 | |
| Disease | obsessive-compulsive disorder | 2.14e-03 | 100 | 75 | 3 | EFO_0004242 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.31e-03 | 28 | 75 | 2 | DOID:12236 (biomarker_via_orthology) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.48e-03 | 29 | 75 | 2 | cv:C5779548 | |
| Disease | Parkinsonism (implicated_via_orthology) | 2.48e-03 | 29 | 75 | 2 | DOID:0080855 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSFKALPYVCLLIAM | 1686 | O00555 | |
| LSIFAPFLTLQLAYM | 211 | P49069 | |
| PCVLISFMVNLVFYL | 256 | Q07001 | |
| ALPYVCLLIAMLFFI | 1606 | Q15878 | |
| YVSLNFIFGLCTMLI | 4571 | Q86UQ4 | |
| PLISVYFALCLSLMV | 306 | Q8WXA8 | |
| FFAPCLIMILVYLRI | 181 | P18089 | |
| NFLGFLLPLLIMSYC | 196 | P49238 | |
| LTLVTECFMAYLYPL | 226 | A2RUS2 | |
| PFEYMILATIIANCI | 96 | Q00975 | |
| FKALPYVCLLIAMLF | 1596 | Q00975 | |
| VLVLYAIFLCFSIMI | 591 | Q8NFF2 | |
| FANIYLAPLSLIVIM | 326 | Q9Y5X5 | |
| FTTVCIPRFLYNISM | 71 | Q9NZP2 | |
| YVAICSPLLYNVIMS | 136 | Q6IF36 | |
| VLFLFLCLVYMTTLL | 26 | Q8NGI4 | |
| PMTLGIYLQLFFLSI | 6 | Q9Y215 | |
| FIMFPFCLILVSYTR | 206 | Q8NGE5 | |
| ILISYFFICITIQRM | 211 | A6NL26 | |
| ILAIYCFCMLQIPSS | 11 | Q5H8A3 | |
| QTELFMPICATYLLI | 56 | Q9HB89 | |
| FSPAMCLLIYLYSLV | 356 | Q6UWP7 | |
| TISYMGCAIQLFLFL | 91 | Q7Z3T1 | |
| MILLAVLFLCFISSY | 1 | P55157 | |
| IVPLLIMLFCYGFTL | 221 | P25025 | |
| LFNNMLLYCVPKFSL | 446 | Q96M96 | |
| AILCYLLVFPLAVFM | 306 | Q96J66 | |
| LLMTPFCLVLLSYIQ | 206 | Q13607 | |
| LLMTPFCLVLLSYIR | 206 | O95006 | |
| LLFPLCSAMYLVTLL | 26 | Q8NGT2 | |
| FSYPFLVLQMCILTL | 301 | Q6NUT2 | |
| PLFLVFLVLYVLTMA | 26 | Q8NGG0 | |
| PRLQIPMYFFLCNLS | 51 | Q8NH79 | |
| LTGIFLCYSITFLMI | 626 | O00222 | |
| ISFVPCIMQTFLYLA | 91 | Q6IF42 | |
| DLLVAIMCLPFTFVY | 86 | P25929 | |
| TVLAMYLICFTPSNL | 291 | P55085 | |
| MVVLLVFALCYLPIS | 301 | O43613 | |
| MFYTINLIIPCLFIS | 241 | Q15825 | |
| LVVACYLLPFLLMCF | 281 | Q8IZ08 | |
| HKCYTFLIFMVLLLP | 516 | Q5T3F8 | |
| CSVVAFYIPFLLMVL | 196 | Q13639 | |
| SYNSVFPMVYCILLL | 411 | Q96T53 | |
| LFLFNNMLLYCVPRV | 341 | Q7Z6J4 | |
| IFLCYIITFLMIAKP | 636 | Q14831 | |
| FIMVVAIVFITCYLP | 221 | Q9BXC0 | |
| YVMCSLLYPLVTFFL | 356 | Q8IWA5 | |
| SSMPCFYLILQYVLL | 426 | A6NIM6 | |
| MFIVSLLLIPYPLCS | 811 | Q3KNS1 | |
| PSFQCALYLIRLLMV | 1126 | Q9BXW9 | |
| PMYILLANFSFLEIC | 96 | Q8NGC1 | |
| FVACGIQIFLYLTMI | 91 | Q8NH01 | |
| EILMILCVSFLVYPN | 211 | O14829 | |
| TPFLCIIFSYLRIMV | 246 | Q8NGR2 | |
| FSTCSPQLIVIMLFL | 236 | A6ND48 | |
| NILMPALTILASYIF | 206 | P0DMU2 | |
| PVCLQFFTLTLMNLY | 121 | O60478 | |
| FIVLCQLTLQSYPRM | 216 | A6NKG5 | |
| VTSFLLLCAIYFLSM | 231 | P59541 | |
| VISFLMLCAIYFLSI | 231 | P0DSN6 | |
| VTSFLLLCAIYFLSM | 231 | P0DTE0 | |
| FYNACFMIIPTLIIS | 206 | Q76EJ3 | |
| MLCITFQIPASVLYK | 461 | Q32P41 | |
| FVLLIFIVSMIYLAC | 1616 | Q9UPZ6 | |
| CLLVVSYQQPLSIFM | 486 | Q9BXQ6 | |
| LQRMITAPCILFLFY | 216 | Q8WUG5 | |
| SLSCNPIYMLFILVS | 311 | P46721 | |
| TPMLQSFINYCLLFL | 71 | Q8IXU6 | |
| YSIIPCFIFVELVIM | 11 | Q8TBJ4 | |
| TPMYFFLCNLSILDI | 56 | Q8NGC5 | |
| ELTCLFMQFSIVPYL | 36 | Q96BI1 | |
| LCAMLPLLLFTYLNS | 86 | Q99808 | |
| LLVITQLGFCSVYFM | 141 | Q495N2 | |
| FRLPLSYFLVGIMCI | 271 | Q8TDI8 | |
| LFPLMLVFILCLYVH | 181 | Q01718 | |
| FIIGYLFPLLTMSIC | 211 | P46091 | |
| LTMYNICFTSLPILA | 911 | Q8NB49 | |
| YFVFCLQIIISIGLM | 311 | Q6YI46 | |
| LISTLIYKFLNVPMF | 246 | O14980 | |
| GCPQMFLYFLVISVI | 546 | Q9NYB5 | |
| MISFLFQLLYFPLIC | 416 | Q9NPD5 | |
| AFCLYMLKTIRLPTF | 331 | Q8TCT7 | |
| YCLLPMILLSSFAVI | 186 | Q969M3 | |
| QLICSYILRPVAFLM | 461 | O00337 | |
| ALCIMLIFTVIYFSI | 256 | P31645 | |
| SVDLRIYMLCFLPFI | 206 | Q6YBV0 | |
| IYMLCFLPFIILLVF | 211 | Q6YBV0 | |
| PLVIFYLSFISMVIC | 346 | O76024 |